NYU Langone Inflammatory Bowel Disease Center — New York, New York

NYU Langone Inflammatory Bowel Disease Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Inflammatory Bowel Disease Center has participated in 2 clinical trials.

Therapeutic areas: Crohn's Disease, Crohn Disease.

Sponsors: Pfizer, Takeda.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Inflammatory Bowel Disease Center?

NYU Langone Inflammatory Bowel Disease Center has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Inflammatory Bowel Disease Center conducted?

NYU Langone Inflammatory Bowel Disease Center has 2 clinical trials on record. Their work covers Crohn's Disease, Crohn Disease.

Is NYU Langone Inflammatory Bowel Disease Center accredited by Crixeo Health?

NYU Langone Inflammatory Bowel Disease Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Inflammatory Bowel Disease Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.